Global Pembrolizumab Market Growth 2023-2029

March 2023 | 74 pages | ID: GDD0C6B8767EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

LPI (LP Information)' newest research report, the “Pembrolizumab Industry Forecast” looks at past sales and reviews total world Pembrolizumab sales in 2022, providing a comprehensive analysis by region and market sector of projected Pembrolizumab sales for 2023 through 2029. With Pembrolizumab sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pembrolizumab industry.

This Insight Report provides a comprehensive analysis of the global Pembrolizumab landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pembrolizumab portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Pembrolizumab market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pembrolizumab and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pembrolizumab.

The global Pembrolizumab market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Pembrolizumab is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Pembrolizumab is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Pembrolizumab is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Pembrolizumab players cover Merck. etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Pembrolizumab market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type

• 50mg Injection
• 100mg Injection

Segmentation by application

• Advanced Melanoma
• Head and Neck Squamous Cell Carcinoma (HNSCC)
• Unresectable or Metastatic Solid Tumor
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Merck

Key Questions Addressed in this Report

What is the 10-year outlook for the global Pembrolizumab market?

What factors are driving Pembrolizumab market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Pembrolizumab market opportunities vary by end market size?

How does Pembrolizumab break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Pembrolizumab Annual Sales 2018-2029
  2.1.2 World Current & Future Analysis for Pembrolizumab by Geographic Region, 2018, 2022 & 2029
  2.1.3 World Current & Future Analysis for Pembrolizumab by Country/Region, 2018, 2022 & 2029
2.2 Pembrolizumab Segment by Type
  2.2.1 50mg Injection
  2.2.2 100mg Injection
2.3 Pembrolizumab Sales by Type
  2.3.1 Global Pembrolizumab Sales Market Share by Type (2018-2023)
  2.3.2 Global Pembrolizumab Revenue and Market Share by Type (2018-2023)
  2.3.3 Global Pembrolizumab Sale Price by Type (2018-2023)
2.4 Pembrolizumab Segment by Application
  2.4.1 Advanced Melanoma
  2.4.2 Head and Neck Squamous Cell Carcinoma (HNSCC)
  2.4.3 Unresectable or Metastatic Solid Tumor
  2.4.4 Other
2.5 Pembrolizumab Sales by Application
  2.5.1 Global Pembrolizumab Sale Market Share by Application (2018-2023)
  2.5.2 Global Pembrolizumab Revenue and Market Share by Application (2018-2023)
  2.5.3 Global Pembrolizumab Sale Price by Application (2018-2023)

3 GLOBAL PEMBROLIZUMAB BY COMPANY

3.1 Global Pembrolizumab Breakdown Data by Company
  3.1.1 Global Pembrolizumab Annual Sales by Company (2018-2023)
  3.1.2 Global Pembrolizumab Sales Market Share by Company (2018-2023)
3.2 Global Pembrolizumab Annual Revenue by Company (2018-2023)
  3.2.1 Global Pembrolizumab Revenue by Company (2018-2023)
  3.2.2 Global Pembrolizumab Revenue Market Share by Company (2018-2023)
3.3 Global Pembrolizumab Sale Price by Company
3.4 Key Manufacturers Pembrolizumab Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Pembrolizumab Product Location Distribution
  3.4.2 Players Pembrolizumab Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR PEMBROLIZUMAB BY GEOGRAPHIC REGION

4.1 World Historic Pembrolizumab Market Size by Geographic Region (2018-2023)
  4.1.1 Global Pembrolizumab Annual Sales by Geographic Region (2018-2023)
  4.1.2 Global Pembrolizumab Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Pembrolizumab Market Size by Country/Region (2018-2023)
  4.2.1 Global Pembrolizumab Annual Sales by Country/Region (2018-2023)
  4.2.2 Global Pembrolizumab Annual Revenue by Country/Region (2018-2023)
4.3 Americas Pembrolizumab Sales Growth
4.4 APAC Pembrolizumab Sales Growth
4.5 Europe Pembrolizumab Sales Growth
4.6 Middle East & Africa Pembrolizumab Sales Growth

5 AMERICAS

5.1 Americas Pembrolizumab Sales by Country
  5.1.1 Americas Pembrolizumab Sales by Country (2018-2023)
  5.1.2 Americas Pembrolizumab Revenue by Country (2018-2023)
5.2 Americas Pembrolizumab Sales by Type
5.3 Americas Pembrolizumab Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Pembrolizumab Sales by Region
  6.1.1 APAC Pembrolizumab Sales by Region (2018-2023)
  6.1.2 APAC Pembrolizumab Revenue by Region (2018-2023)
6.2 APAC Pembrolizumab Sales by Type
6.3 APAC Pembrolizumab Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Pembrolizumab by Country
  7.1.1 Europe Pembrolizumab Sales by Country (2018-2023)
  7.1.2 Europe Pembrolizumab Revenue by Country (2018-2023)
7.2 Europe Pembrolizumab Sales by Type
7.3 Europe Pembrolizumab Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Pembrolizumab by Country
  8.1.1 Middle East & Africa Pembrolizumab Sales by Country (2018-2023)
  8.1.2 Middle East & Africa Pembrolizumab Revenue by Country (2018-2023)
8.2 Middle East & Africa Pembrolizumab Sales by Type
8.3 Middle East & Africa Pembrolizumab Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pembrolizumab
10.3 Manufacturing Process Analysis of Pembrolizumab
10.4 Industry Chain Structure of Pembrolizumab

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Pembrolizumab Distributors
11.3 Pembrolizumab Customer

12 WORLD FORECAST REVIEW FOR PEMBROLIZUMAB BY GEOGRAPHIC REGION

12.1 Global Pembrolizumab Market Size Forecast by Region
  12.1.1 Global Pembrolizumab Forecast by Region (2024-2029)
  12.1.2 Global Pembrolizumab Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Pembrolizumab Forecast by Type
12.7 Global Pembrolizumab Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 Merck
  13.1.1 Merck Company Information
  13.1.2 Merck Pembrolizumab Product Portfolios and Specifications
  13.1.3 Merck Pembrolizumab Sales, Revenue, Price and Gross Margin (2018-2023)
  13.1.4 Merck Main Business Overview
  13.1.5 Merck Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Pembrolizumab Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Pembrolizumab Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 50mg Injection
Table 4. Major Players of 100mg Injection
Table 5. Global Pembrolizumab Sales by Type (2018-2023) & (K Pcs)
Table 6. Global Pembrolizumab Sales Market Share by Type (2018-2023)
Table 7. Global Pembrolizumab Revenue by Type (2018-2023) & ($ million)
Table 8. Global Pembrolizumab Revenue Market Share by Type (2018-2023)
Table 9. Global Pembrolizumab Sale Price by Type (2018-2023) & (USD/Pcs)
Table 10. Global Pembrolizumab Sales by Application (2018-2023) & (K Pcs)
Table 11. Global Pembrolizumab Sales Market Share by Application (2018-2023)
Table 12. Global Pembrolizumab Revenue by Application (2018-2023)
Table 13. Global Pembrolizumab Revenue Market Share by Application (2018-2023)
Table 14. Global Pembrolizumab Sale Price by Application (2018-2023) & (USD/Pcs)
Table 15. Global Pembrolizumab Sales by Company (2018-2023) & (K Pcs)
Table 16. Global Pembrolizumab Sales Market Share by Company (2018-2023)
Table 17. Global Pembrolizumab Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Pembrolizumab Revenue Market Share by Company (2018-2023)
Table 19. Global Pembrolizumab Sale Price by Company (2018-2023) & (USD/Pcs)
Table 20. Key Manufacturers Pembrolizumab Producing Area Distribution and Sales Area
Table 21. Players Pembrolizumab Products Offered
Table 22. Pembrolizumab Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Pembrolizumab Sales by Geographic Region (2018-2023) & (K Pcs)
Table 26. Global Pembrolizumab Sales Market Share Geographic Region (2018-2023)
Table 27. Global Pembrolizumab Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Pembrolizumab Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Pembrolizumab Sales by Country/Region (2018-2023) & (K Pcs)
Table 30. Global Pembrolizumab Sales Market Share by Country/Region (2018-2023)
Table 31. Global Pembrolizumab Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Pembrolizumab Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Pembrolizumab Sales by Country (2018-2023) & (K Pcs)
Table 34. Americas Pembrolizumab Sales Market Share by Country (2018-2023)
Table 35. Americas Pembrolizumab Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Pembrolizumab Revenue Market Share by Country (2018-2023)
Table 37. Americas Pembrolizumab Sales by Type (2018-2023) & (K Pcs)
Table 38. Americas Pembrolizumab Sales by Application (2018-2023) & (K Pcs)
Table 39. APAC Pembrolizumab Sales by Region (2018-2023) & (K Pcs)
Table 40. APAC Pembrolizumab Sales Market Share by Region (2018-2023)
Table 41. APAC Pembrolizumab Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Pembrolizumab Revenue Market Share by Region (2018-2023)
Table 43. APAC Pembrolizumab Sales by Type (2018-2023) & (K Pcs)
Table 44. APAC Pembrolizumab Sales by Application (2018-2023) & (K Pcs)
Table 45. Europe Pembrolizumab Sales by Country (2018-2023) & (K Pcs)
Table 46. Europe Pembrolizumab Sales Market Share by Country (2018-2023)
Table 47. Europe Pembrolizumab Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Pembrolizumab Revenue Market Share by Country (2018-2023)
Table 49. Europe Pembrolizumab Sales by Type (2018-2023) & (K Pcs)
Table 50. Europe Pembrolizumab Sales by Application (2018-2023) & (K Pcs)
Table 51. Middle East & Africa Pembrolizumab Sales by Country (2018-2023) & (K Pcs)
Table 52. Middle East & Africa Pembrolizumab Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Pembrolizumab Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Pembrolizumab Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Pembrolizumab Sales by Type (2018-2023) & (K Pcs)
Table 56. Middle East & Africa Pembrolizumab Sales by Application (2018-2023) & (K Pcs)
Table 57. Key Market Drivers & Growth Opportunities of Pembrolizumab
Table 58. Key Market Challenges & Risks of Pembrolizumab
Table 59. Key Industry Trends of Pembrolizumab
Table 60. Pembrolizumab Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Pembrolizumab Distributors List
Table 63. Pembrolizumab Customer List
Table 64. Global Pembrolizumab Sales Forecast by Region (2024-2029) & (K Pcs)
Table 65. Global Pembrolizumab Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Pembrolizumab Sales Forecast by Country (2024-2029) & (K Pcs)
Table 67. Americas Pembrolizumab Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Pembrolizumab Sales Forecast by Region (2024-2029) & (K Pcs)
Table 69. APAC Pembrolizumab Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Pembrolizumab Sales Forecast by Country (2024-2029) & (K Pcs)
Table 71. Europe Pembrolizumab Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Pembrolizumab Sales Forecast by Country (2024-2029) & (K Pcs)
Table 73. Middle East & Africa Pembrolizumab Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Pembrolizumab Sales Forecast by Type (2024-2029) & (K Pcs)
Table 75. Global Pembrolizumab Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Pembrolizumab Sales Forecast by Application (2024-2029) & (K Pcs)
Table 77. Global Pembrolizumab Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Merck Basic Information, Pembrolizumab Manufacturing Base, Sales Area and Its Competitors
Table 79. Merck Pembrolizumab Product Portfolios and Specifications
Table 80. Merck Pembrolizumab Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 81. Merck Main Business
Table 82. Merck Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Pembrolizumab
Figure 2. Pembrolizumab Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pembrolizumab Sales Growth Rate 2018-2029 (K Pcs)
Figure 7. Global Pembrolizumab Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Pembrolizumab Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 50mg Injection
Figure 10. Product Picture of 100mg Injection
Figure 11. Global Pembrolizumab Sales Market Share by Type in 2022
Figure 12. Global Pembrolizumab Revenue Market Share by Type (2018-2023)
Figure 13. Pembrolizumab Consumed in Advanced Melanoma
Figure 14. Global Pembrolizumab Market: Advanced Melanoma (2018-2023) & (K Pcs)
Figure 15. Pembrolizumab Consumed in Head and Neck Squamous Cell Carcinoma (HNSCC)
Figure 16. Global Pembrolizumab Market: Head and Neck Squamous Cell Carcinoma (HNSCC) (2018-2023) & (K Pcs)
Figure 17. Pembrolizumab Consumed in Unresectable or Metastatic Solid Tumor
Figure 18. Global Pembrolizumab Market: Unresectable or Metastatic Solid Tumor (2018-2023) & (K Pcs)
Figure 19. Pembrolizumab Consumed in Other
Figure 20. Global Pembrolizumab Market: Other (2018-2023) & (K Pcs)
Figure 21. Global Pembrolizumab Sales Market Share by Application (2022)
Figure 22. Global Pembrolizumab Revenue Market Share by Application in 2022
Figure 23. Pembrolizumab Sales Market by Company in 2022 (K Pcs)
Figure 24. Global Pembrolizumab Sales Market Share by Company in 2022
Figure 25. Pembrolizumab Revenue Market by Company in 2022 ($ Million)
Figure 26. Global Pembrolizumab Revenue Market Share by Company in 2022
Figure 27. Global Pembrolizumab Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global Pembrolizumab Revenue Market Share by Geographic Region in 2022
Figure 29. Americas Pembrolizumab Sales 2018-2023 (K Pcs)
Figure 30. Americas Pembrolizumab Revenue 2018-2023 ($ Millions)
Figure 31. APAC Pembrolizumab Sales 2018-2023 (K Pcs)
Figure 32. APAC Pembrolizumab Revenue 2018-2023 ($ Millions)
Figure 33. Europe Pembrolizumab Sales 2018-2023 (K Pcs)
Figure 34. Europe Pembrolizumab Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa Pembrolizumab Sales 2018-2023 (K Pcs)
Figure 36. Middle East & Africa Pembrolizumab Revenue 2018-2023 ($ Millions)
Figure 37. Americas Pembrolizumab Sales Market Share by Country in 2022
Figure 38. Americas Pembrolizumab Revenue Market Share by Country in 2022
Figure 39. Americas Pembrolizumab Sales Market Share by Type (2018-2023)
Figure 40. Americas Pembrolizumab Sales Market Share by Application (2018-2023)
Figure 41. United States Pembrolizumab Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada Pembrolizumab Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico Pembrolizumab Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil Pembrolizumab Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC Pembrolizumab Sales Market Share by Region in 2022
Figure 46. APAC Pembrolizumab Revenue Market Share by Regions in 2022
Figure 47. APAC Pembrolizumab Sales Market Share by Type (2018-2023)
Figure 48. APAC Pembrolizumab Sales Market Share by Application (2018-2023)
Figure 49. China Pembrolizumab Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan Pembrolizumab Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea Pembrolizumab Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia Pembrolizumab Revenue Growth 2018-2023 ($ Millions)
Figure 53. India Pembrolizumab Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia Pembrolizumab Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan Pembrolizumab Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe Pembrolizumab Sales Market Share by Country in 2022
Figure 57. Europe Pembrolizumab Revenue Market Share by Country in 2022
Figure 58. Europe Pembrolizumab Sales Market Share by Type (2018-2023)
Figure 59. Europe Pembrolizumab Sales Market Share by Application (2018-2023)
Figure 60. Germany Pembrolizumab Revenue Growth 2018-2023 ($ Millions)
Figure 61. France Pembrolizumab Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK Pembrolizumab Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy Pembrolizumab Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia Pembrolizumab Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa Pembrolizumab Sales Market Share by Country in 2022
Figure 66. Middle East & Africa Pembrolizumab Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa Pembrolizumab Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa Pembrolizumab Sales Market Share by Application (2018-2023)
Figure 69. Egypt Pembrolizumab Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa Pembrolizumab Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel Pembrolizumab Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey Pembrolizumab Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country Pembrolizumab Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Pembrolizumab in 2022
Figure 75. Manufacturing Process Analysis of Pembrolizumab
Figure 76. Industry Chain Structure of Pembrolizumab
Figure 77. Channels of Distribution
Figure 78. Global Pembrolizumab Sales Market Forecast by Region (2024-2029)
Figure 79. Global Pembrolizumab Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global Pembrolizumab Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global Pembrolizumab Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global Pembrolizumab Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global Pembrolizumab Revenue Market Share Forecast by Application (2024-2029)